2021
Laboratory evaluation and prognostication among adults and children with CEBPA‐mutant acute myeloid leukemia
Mendoza H, Podoltsev NA, Siddon AJ. Laboratory evaluation and prognostication among adults and children with CEBPA‐mutant acute myeloid leukemia. International Journal Of Laboratory Hematology 2021, 43: 86-95. PMID: 34288448, DOI: 10.1111/ijlh.13517.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCEBPA mutant acute myeloid leukemiaAcute myeloid leukemiaCEBPA mutationsMyeloid leukemiaLeukemogenic mutationsPositive prognostic impactSingle CEBPA mutationsSimilar survival outcomesNegative prognostic effectFLT3-ITD mutationLaboratory evaluationWild-type CEBPAMultiparameter flow cytometryGermline CEBPA mutationsFavorable prognosisPrognostic impactMutation presencePrognostic effectRisk stratificationSurvival outcomesGATA2 mutationsDistinct subtypesMolecular findingsCEBPA geneFlow cytometry
2010
Overview of the Lymphoid Neoplasms
Podoltsev N, Lacy J, Vose J. Overview of the Lymphoid Neoplasms. 2010, 3-39. DOI: 10.1007/978-1-4419-7668-0_1.Peer-Reviewed Original ResearchNon-Hodgkin lymphomaHodgkin's lymphomaPathogenesis of lymphomaHistologic featuresEtiologic factorsCommon subtypeWHO classificationTreatment outcomesCell neoplasmsClinical aspectsClinical groupingLymphoid malignanciesLymphoma pathogenesisLymphoid cellsLymphoid neoplasmsNormal lymphocytesLymphomaImmune systemDistinct subtypesNeoplasmsLymphocyte developmentSecond portionPathogenesisSubtypesGenetic events